Terns Pharmceuticals

Terns Pharmaceuticals touts safety data from an ex-Eli Lilly candidate in the hunt for NASH treatment
Endpoints
Tue, 06/15/21 - 11:35 pm
Terns Pharmceuticals
Eli Lilly
FXR agonists
NASH